Spinal Cord Injury Therapeutics Market, By Drug Type, By Indication, By Application, By Route of Administration, By Distribution Channel, By Geography

Description

The Global Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 7.4 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.40%	2030 Value Projection:	US$ 10.7 Bn

Figure 1. Global Spinal Cord Injury Therapeutics Market Share (%), By Indication, 2023

Spinal Cord Injury Therapeutics Market - IMG1

Spinal cord wounds are the wounds caused to the 31 sets of spinal nerves, which convey nerve signals from the mind to different parts of the body and likewise control the arm and leg developments. The fundamental driver of spinal cord wounds incorporate injury, loss of blood supply to the spinal cord, and pressure in the spinal cord because of cancer or contamination. Spinal cord wounds can be determined to have the assistance of different methods, for example, X-beam, attractive reverberation record (MRI), and figured tomography (CT). Key players in the pharmaceutical industry are focusing on the development of drugs associated with the treatment of spinal cord injuries. Thus, the introduction of such advanced products in the market is expected to drive the growth of the global spinal cord injury therapeutics market over the forecast period.

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of new drugs for spinal cord injury treatment. Thus, the introduction of such advanced products in the market is expected to drive growth of the global spinal cord injury therapeutics market over the forecast period. For instance, in June 2022, Amneal Pharmaceuticals, Inc., a fully integrated essential medicines company, announced the commercial launch of LYVISPAH, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity related to multiple sclerosis and other spinal cord disorders.

Key features of the study:

This report provides an in-depth analysis of the global spinal cord injury therapeutics market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global spinal cord injury therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc, Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc, RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc, ScieGen Pharmaceuticals, Inc, MSN Laboratories Private Limited, and Lannett Co Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global spinal cord injury therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market

Global Spinal Cord Injury Therapeutics Market Detailed Segmentation:

By Drug Type:
- Corticosteroids
- Muscle Relaxants and Anti-spastic drugs
- Non-steroidal Anti-inflammatory drugs (NSAID'S)
- Anti-depressants
- Anticonvulsants
- Others
By Indication:
- Complete Spinal Cord Injury
- Incomplete Spinal Cord Injury
By Application:
- Autonomic Dysreflexia (AD)
- Spasticity and Inflammation
- Pain Management
- Depression
By Route of Administration:
- Oral
- Intravenous
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc
- Pfizer Inc.
- Reddy's Laboratories Ltd
- Zydus Cadila
- ReNetX Bio, Inc
- InVivo Therapeutics Holdings
- Lineage Cell Therapeutics, Inc
- Kringle Pharma, Inc.
- Acorda Therapeutics, Inc.
- Bioaxone Biosciences, Inc
- RespireRx Pharmaceuticals Inc.
- NervGen
- Rising Pharmaceuticals, Inc
- ScieGen Pharmaceuticals, Inc
- MSN Laboratories Private Limited
- Lannett Co Inc.
- Other Prominent Players

Product Code: CMI4305

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Spinal Cord Injury Therapeutics Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Muscle Relaxants and Anti-spastic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Non-steroidal Anti-inflammatory Drugs (NSAID'S)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Anti-depressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Spinal Cord Injury Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Complete Spinal Cord Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Incomplete Spinal Cord Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Spinal Cord Injury Therapeutics Market, By Application, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Autonomic Dysreflexia (AD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Spasticity and Inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

10. Global Spinal Cord Injury Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

11. Competitive Landscape

Company Profiles
- Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- AbbVie Inc
- Pfizer Inc.
- Reddy's Laboratories Ltd
- Zydus Cadila
- ReNetX Bio, Inc
- InVivo Therapeutics Holdings
- Lineage Cell Therapeutics, Inc
- Kringle Pharma, Inc.
- Acorda Therapeutics, Inc.
- Bioaxone Biosciences, Inc
- RespireRx Pharmaceuticals Inc.
- NervGen
- Rising Pharmaceuticals, Inc
- ScieGen Pharmaceuticals, Inc
- MSN Laboratories Private Limited
- Lannett Co Inc.
- Other Prominent Players

12. Section

References
Research Methodology
About us and Sales Contact